TERT and neoplasm: We attributed the latter to the capacity of TERT as an enzyme to in vivo synthesize short RNA and DNA/RNA hybrids which can trigger innate immune response against tumor cells artificially made to overexpress TERT [35], and also act as molecular adjuvants enhancing the immunogenicity of TERT.